Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Mineralys Therapeutics Names New Chief Medical Officer

Mineralys Therapeutics, Inc. filed a Form 8-K on August 11, 2026, disclosing the appointment of a new Chief Medical Officer effective August 10, 2026, and announcing financial results for the quarter ended June 30, 2026.

Manish Choudhary | 11 August 2026

Griffon Corporation Prices $800M Senior Notes Due 2034

Griffon Corporation filed a Form 8-K with the SEC on August 11, 2026, disclosing that on August 10, 2026, the company entered into a Purchase Agreement to issue and sell $800 million aggregate principal amount of 6.25% senior notes due 2034.

Vinay Lochav | 11 August 2026

DoorDash CEO Tony Xu Reports Class A Stock Changes

A Form 4 filed with the SEC on August 11, 2026, discloses changes in beneficial ownership of DoorDash, Inc. (NASDAQ:DASH) Class A Common Stock by Chief Executive Officer and Director Tony Xu, reflecting transactions dated August 7, 2026.

Manish Choudhary | 11 August 2026

DoorDash Stockholders Approve Nevada Reincorporation

DoorDash, Inc. filed a Form 8-K on August 11, 2026, disclosing that certain stockholders holding a majority of voting power approved the company's reincorporation from Delaware to Nevada by written consent on August 6, 2026.

Anjali Anand | 11 August 2026

Factorial Energy Reports Q2 2026 Financial Results

Factorial Energy Inc. filed a current report on August 11, 2026, disclosing its financial results for the quarter ended June 30, 2026, along with an updated investor presentation released under Regulation FD.

Aakashdeep | 11 August 2026

Vor Biopharma Files Q2 2026 Quarterly Report

Vor Biopharma Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, disclosing financial statements and operational information for the three and six months ended June 30, 2026.

Nitish Kishor | 11 August 2026

SELLAS Life Sciences Files Q2 2026 Quarterly Report

SELLAS Life Sciences Group, Inc. filed its Form 10-Q with the SEC on August 11, 2026, covering the quarterly period ended June 30, 2026, disclosing balance sheet figures and share count changes for the first half of the fiscal year.

Manish Choudhary | 11 August 2026

Hemab Therapeutics Files Q2 2026 Quarterly Report

Hemab Therapeutics Holdings, Inc. filed its Form 10-Q with the U.S. Securities and Exchange Commission on August 11, 2026, covering the quarterly period ended June 30, 2026, disclosing its financial condition, pipeline status, and risk factors as a clinical-stage biopharmaceutical company.

Nitish Kishor | 11 August 2026

Helios Technologies Q2 2026 Quarterly Results Disclosed

Helios Technologies, Inc. filed its Form 10-Q for the quarterly period ended July 4, 2026 with the U.S. Securities and Exchange Commission, reporting consolidated financial results for the three and six months ended on that date.

Nitish Kishor | 11 August 2026

Gladstone Land Posts Q2 2026 Net Loss of $8.5 Million

Gladstone Land Corporation filed its Form 10-Q for the quarterly period ended June 30, 2026, with the SEC on August 11, 2026, reporting a net loss of $8.46 million for the second quarter and a net loss attributable to common stockholders of $13.52 million.

Nitish Kishor | 11 August 2026
Support

Hi! How can we help you today?

Loading…